144 A Clinical Practice Assessment In Tardive Dyskinesia: Are Physicians Up-to-Date?

Abstract

Study Objectives: To assess physicians' currentknowledge, skills, competence, and practice barriersregarding tardive dyskinesia (TD) and assess continuingmedical education (CME) needs.ASSESSMENT METHODS: A 29-question clinical practiceassessment survey instrument consisting of multiplechoice knowledge and case-based questions was administered online to gather abaseline "snapshot" of knowledge,skills, attitudes, and competence on TD epidemiology,risk factors, diagnosis, current guideline-based management, and emerging management strategiesThe survey launched online on a website dedicated tocontinuous professional development on July 25, 2016,and was made available to healthcare providers withoutmonetary compensation or charge. Data were collectedthrough August 28, 2016Confidentiality was maintained and responses werede-identified and aggregated prior to analysesRESULTS: Data were collected for the 1157 psychiatristsand 177 neurologists who responded to all surveyquestions during the study period. The findings were:• Epidemiology: 62% of psychiatrists and 68% ofneurologists were aware that TD affects approximately20% of patients treated with neuroleptic agents• Risk factors: 63% of psychiatrists and 67% ofneurologists were aware of risk factors for TD, suchas older age• Diagnosis: 93% of psychiatrists and 71% of neurologists were aware that Abnormal Involuntary Movement Scale (AIMS) can be used to supportdiagnosis of TD• Guidelines: 21% of psychiatrists and 11% of neurologists were aware of the American Psychiatric Association guidelines for monitoring of TD, and 56% ofpsychiatrists and 42% of neurologists were aware ofthe American Academy of Neurology guidelines ontreatment of TDNew/emerging treatments: 24% of psychiatrists and 34% ofneurologists were aware of the mechanisms of action ofnew/emerging treatments for TD, and 54% and 44%,respectively, were aware of the clinical data for valbenazineCONCLUSIONS: This educational research yielded important insights into clinical practice gaps in TD, indicatingthat both psychiatrists and neurologists would benefitfrom continuing medical education on epidemiology,risk factors, diagnosis, guideline-based care, and information on how to incorporate new/emerging treatmentsfor TD into practice.